Mechanistically, the enhanced expression of SAAs in hepatocytes (Hep1 cells) was induced by activation of the JAK-STAT3 pathway, which was triggered by the secretion of C-X-C Motif Chemokine Ligand 6 (CXCL6) by invasive tumor cells. Here, STAT3 is linked to neoplasm.